Medtech startup Aevice Health raises S$2.8m, secures commercialisation partnership

MEDTECH startup Aevice Health has raised a S$2.8 million pre-Series A funding round and secured a collaboration with Tokyo-listed Toho Holdings, which invested in the round.

Other investors include medtech investor Pureland Group Venture, Singapore-based Silicon Solutions Partners, AIP Ventures and Enterprise Singapore's SEEDS Capital.

Aevice is developing wearables that can help remotely monitor patients with respiratory conditions. The startup will work with Toho, a wholesaler of medicine, medical tools and equipment with over 700 pharmacies across Japan, to develop and commercialise its device AeviceMD.

Chronic respiratory diseases are the top few leading causes of death in Japan, said the startup in a press statement. Many patients, especially the elderly with higher comorbidities, require regular check-ups and constant monitoring.

With the disparity in the number of physicians between urban and rural parts of Japan widening, many patients living in rural parts of Japan may face difficulties accessing regular care for their chronic conditions.

AeviceMD is a wearable smart stethoscope meant to complement telehealth services to facilitate self-management of chronic diseases. It listens to the patient's chest sounds remotely, continuously and in real time, and detects cardiopulmonary abnormalities (such as wheezing) that are typical of chronic respiratory diseases.

Aevice Health also has a partnership with THB Global, a home care, healthcare and chronic disease management company with offices in Singapore, Dubai and Pakistan. The company is helping with remote monitoring of chronic respiratory diseases in the Middle East, North Africa and South Asia region.

READ MORE: AEvice brings wearables and the cloud to paediatric asthma treatment